Enzymatic Hydrogel-Cell Composition for Stable Cell Encapsulation

The patent replaces chemical cross-linking mechanisms with enzymatic cross-linking. Specifically, transglutaminase enzymes catalyze the formation of covalent bonds between glutamine and lysine residues in gelatin molecules, creating a stable hydrogel network without requiring toxic chemical cross-linkers. This enzymatic approach maintains mechanical stability while eliminating harmful chemical effects on encapsulated cells.

The patent introduces enzymes as intermediary agents that mediate the cross-linking process. Transglutaminase acts as a biocompatible catalyst that facilitates polymerization between gelatin chains, serving as a non-toxic intermediary that enables hydrogel formation while protecting cell viability. The enzyme mediates the chemical reaction without directly contacting or harming the encapsulated cells.

The patent creates a composite hydrogel system by combining gelatin (animal-derived protein) with controlled enzymatic cross-linking. The gelatin provides biocompatibility and biological functionality, while the enzymatically-formed cross-linked network provides mechanical strength and flexibility. This composite approach integrates the advantages of natural proteins with the mechanical properties needed for biomedical applications.

The patent modifies the physical-chemical parameters of gelatin through enzymatic cross-linking. By controlling the degree of cross-linking via enzyme concentration and reaction time, the hydrogel's mechanical properties (flexibility, elasticity, strength) can be tuned while maintaining the biocompatible nature of the gelatin matrix. This allows optimization of both biocompatibility and mechanical flexibility.

The patent performs preliminary action by incorporating cells into the hydrogel matrix during the gelation process itself, rather than adding them to pre-formed hydrogels. Cells are mixed with the gelatin solution before cross-linking occurs, ensuring they are uniformly distributed and immediately protected by the forming hydrogel network. This preliminary incorporation significantly improves cell stability and viability compared to post-formation encapsulation.

The patent merges the cell encapsulation process with the hydrogel formation process into a single integrated operation. Cell mixing, gelation, and cross-linking occur simultaneously in one step, combining what are traditionally separate processes. This merging ensures cells are protected from environmental hazards from the moment of encapsulation, improving long-term stability while maintaining manufacturing simplicity.